Lv1
80 积分 2023-04-04 加入
Variation in Ligand Binding Specificities of a Novel Class of Poxvirus-encoded Tumor Necrosis Factor-binding Protein
5小时前
已完结
The global burden of IBD: from 2015 to 2025
8天前
已完结
Inhibition of Btk with CC-292 Provides Early Pharmacodynamic Assessment of Activity in Mice and Humans
17天前
已完结
Design of a potent interleukin-21 mimic for cancer immunotherapy
21天前
已完结
Dual antibody inhibition of KLK5 and KLK7 for Netherton syndrome and atopic dermatitis
22天前
已完结
Review of Dose Justifications for Antibody-Drug Conjugate Approvals from Clinical Pharmacology Perspective: a Focus on Exposure-Response Analyses
24天前
已完结
The tumour microenvironment in pancreatic cancer — new clinical challenges, but more opportunities
28天前
已完结
BH-30236, a Novel Macrocyclic Clk Inhibitor Modulating Aberrant RNA Splicing, Demonstrates Potent Anti-Cancer Activity Against Myeloid Malignancies
28天前
已完结
Co-targeting of delta-like ligand 4 (DLL4) and vascular endothelial growth factor a (VEGF) with programmed death 1 (PD1) blockade inhibits tumor growth and facilitates anti-tumor immune responses
1个月前
已完结
Navicixizumab plus Paclitaxel Shows Clinical Benefit in Platinum-Resistant Ovarian Cancer
1个月前
已关闭
皖公网安备34019202002308
